You just read:

Shareholder Alert: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Celator Pharmaceuticals, Inc. - CPXX

News provided by

Pomerantz LLP

May 31, 2016, 16:29 ET